Ms. Shaw has over 25 years of experience providing commercial, financial, strategic, medical, clinical development, legal and operations leadership in healthcare. Ms. Shaw is a SVP with Eli Lilly and President of Lilly Bio-Medicines where she oversees late-stage clinical development and commercialization for the company’s leading positions in Immunology, Pain, Migraine and Alzheimer’s disease. Ms. Shaw has held prominent leadership roles at Lilly, Johnson & Johnson and Novartis; most recently, she served as US Country President and President of Novartis until 2016. Ms. Shaw has been recognized with numerous industry awards including: a 2019 Women in Oncology Award (PRIMO), a 2018 Health Visionary Award (Society for Women’s Health Research) and a 2016 Lifetime Achievement Award (Eye for Pharma), among others. Ms. Shaw has served on numerous boards including current positions with the Biotechnology Industry Organization (BIO), the Healthcare Women’s Business Association (HBA), Avantor, and Gra/ey Market.